02.11.2018 • NewsDaelimElaine BurridgeMa’aden

Ma’aden Awards Phosphate Contract to Daelim

Ma’aden Awards Phosphate Contract to Daelim (c) Daelim
Ma’aden Awards Phosphate Contract to Daelim (c) Daelim

Saudi Arabian Mining Company (Ma’aden) has awarded an engineering, procurement and construction (EPC) contract to South Korea’s Daelim for the first plant to be built as part of its third large-scale phosphate complex at Ras Al-Khair on Saudi Arabia’s east coast.

Daelim Industrial and Saudi Daelim will jointly perform EPC services on the plant, which will produce 1.1 million t/y of ammonia. The project will take 38 months to implement.

The complex, known as Phosphate 3, will increase Ma’aden’s phosphate capacity by 3 million t/y to a total of 9 million t/y, making the Kingdom the world’s third-largest producer of phosphate fertilizer and the second-largest exporter.

Ma’aden said the overall project, which is expected to cost $6.4 billion, will be built in stages and phased in by 2024. It will generate non-oil GDP growth of $6.7 billion and create approximately 7,000 direct and indirect jobs.

Daelim recently provided EPC services on an ammonia plant for Ma’aden Waad Al-Shamal Phosphate Company, a joint venture between Ma’aden, SABIC and US fertilizer group Mosaic. The 1.1 million t/y ammonia facility, one of seven plants at the phosphate complex that is also located at Ras Al-Khair, started commercial production in 2017.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

most read

Photo
27.03.2025 • News

J&J to Invest $55 Billion in US Operations

US healthcare giant Johnson & Johnson (J&J) has unveiled plans to invest over $55 billion in the US over the next four years. This significant investment marks a 25% increase compared to the previous four years, the company said.

Photo
21.03.2025 • News

What’s Next for Pharma Supply Chains?

Sudden shifts in demand, supply shortages and global collapse have put immense pressure on pharmaceutical logistics. To address these challenges, PHARMAP 2025 brings together industry experts to discover AI-driven supply chain optimisation, strategic logistics partnerships and digital solutions that enhance efficiency and resilience in the pharmaceutical supply chain.